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Managing chronic oedema  
in community settings
The term chronic oedema acts as an umbrella description of abnormal swelling of tissues which lasts for more than 3 months, 
regardless of whether the aetiology is lymphatic or 
venous in origin. There are a number of causes of 
chronic oedema, including dependency oedema, 
that is to say oedema associated with inactivity and 
immobility, venous oedema (swelling mainly caused 
by the vascular insufficiency) and lymphoedema, 
a chronic swelling due to lymphatic failure. There 
are two main types of lymphoedema, primary and 
secondary. Primary lymphoedema is associated 
with abnormal development of the lymphatics for 
either congenital or genetic reasons. Secondary 
lymphoedema is connected with the lymphatics 
being damaged by surgery, radiotherapy, infection 
(such as cellulitis), burns or trauma. In many cases 
lymphoedema and chronic oedema are intrinsically 
linked, as chronic oedema is caused by the failure 
of the lymphatic system (Mortimer and Rockson, 
2014). Lipoedema is a condition that alters the fat cell 
distribution; causing an abnormal build up of fat in 
the lower limbs. Chronic lipoedema can progress into 
lipo-lymphoedema. 
Chronic oedema can affect people of all ages. 
However, it is most prevalent in older people. It can 
Aim: The aim of this rapid-evidence assessment of the literature is to assess the 
existing evidence relating to the management of cancer and non-cancer related chronic 
oedema/Lymphoedema in the community setting. Methods: Using the PICO (Patient/
Population/Problem Intervention Comparison Outcomes) method online journal 
databases MEDLINE, CINAHL and PUBMED, were searched between June 2016 
and August 2016. Additional studies were identified through searching bibliographies 
of related publications and using the Google Scholar internet search function. The 
following search terms were used in line with the different PICO domains: chronic 
oedema; Lymphoedema; exercise; compression hosiery; compression bandages; 
bandages; hosiery; stockings; self-care; self-management; Health-related quality of life; 
managing chronic oedema; cost of; burden of; economic evaluation; QALY. Results: 
Fifty nine potentially relevant abstracts were found from the search. Twenty one papers 
were chosen for inclusion in the final review – eight US studies, four UK studies, one 
joint UK and Canadian study, four Australian studies, two German studies and one 
study each from Japan and Italy. The papers were thematically categorised (based on 
health-related quality of life and cost burden outcomes of the study) by Self-managing 
chronic oedema, Exercise, Compression devices, Dressings/Stockings, Quality of life 
and Cost studies/Economic burden. Conclusion: There is sufficient evidence in the 
literature that suggests promoting self-management of lymphoedema, the quality of 
life of lymphoedema patients and the correct use of bandages and stockings is vitally 
important to clinical practice. Moreover, these issues have a major impact in the health 
outcomes of patients in the community. This review is a valuable addition to the 
evidence base for both the care and management of lymphoedema, and an opportunity 
to add valuable research into the economic burden of the disease.
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occur in all limbs and, more rarely, the head, neck, 
trunk or genital area. An incurable, progressive and 
debilitating condition that often requires lifelong 
management chronic oedema has a profound effect 
on people’s quality of life and their ability to engage in 
normal daily activities. It also has a significant impact 
on NHS resources as patients can have a number of 
hospital admissions for cellulitis. Cellulitis occurs 
more in patients with chronic oedema as the fluid 
component in the limbs contains proteins and other 
molecules, which is an ideal medium for bacteria. 
In Wales, it is estimated that the prevalence rate 
for the lymphoedema alone is in excess of 5.49 per 
1,000 population, with over 10,500 people with the 
condition. 
There is poor awareness and understanding of 
chronic oedema amongst healthcare professionals. 
Consequently, chronic oedema is frequently 
unrecognised, resulting in diagnostic delay and even 
inappropriate treatment. However, awareness of 
the need for innovative approaches to education 
for healthcare professionals on the various genres 
of chronic oedema, their treatments and available 
resources is improving internationally. 
Lymphoedema Network Wales has been proactive 
in developing innovative methods to support 
the management of chronic oedema within the 
community setting. One innovation is through a 
community-based education model that involves the 
use of video prescription films as well as a practice 
educator to support community health professionals 
and patients in the management and care of the 
patient’s chronic oedema. Whilst this requires 
investment in terms of resources to deliver the model 
of care, it could result in more effective management 
of chronic oedema and improved efficiency of 
correct prescribing of dressings and more effective 
products from the All Wales Lymphoedema 
Compression Garment Formulary. This literature 
review was the precursor to obtaining funding 
from the Welsh Government's Efficiency Through 
Technology Fund for the implementation of this new 
education model with community nurses.
AIM
The aim of this rapid evidence assessment of the 
literature was to assess the existing evidence relating 
to the management of cancer and non-cancer 
related chronic oedema/lymphoedema in the 
community setting. 
METHODS
We used the PICO process to set up the framework 
of the literature strategy since this technique is 
especially useful in answering clinical and/or health 
care related questions (Table 1). Online journal 
databases MEDLINE, CINAHL and PUBMED, 
were searched between June 2016 and August 2016. 
Additional studies were identified through searching 
bibliographies of related publications and using 
the Google Scholar internet search function. The 
inclusion criteria used can be seen in Table 2. The 
exclusion criteria used were:
Non English language publications
Abstracts presented at conferences
Editorials
Studies not available in full text.
To keep the research relevant to up-to-date practice, 
publications prior to 2000 were excluded by the 
searches. The following search terms were used 
in line with the different PICO domains: chronic 
oedema; lymphoedema; exercise; compression 
hosiery; compression bandages; bandages; hosiery; 
stockings; self-care; self-management; health-related 
quality of life; managing chronic oedema; cost of; 
burden of; economic evaluation; QALY.
Figure 1 summarises the search terms (key words) 
used during the literature searches. The literature 
Table 1. PICO strategy
Patient or Population or Problem Intervention Comparison Outcomes
Patients with chronic oedema in 
community settings
A community-based education 
model to support community health 
professionals and patients in the 
management and care of the patient’s 
chronic oedema
No education model/usual care 1. More effective management of chronic 
oedema; economic and patient benefits
2. Health-related quality of life; cost of; 
burden of; economic evaluation, QALY
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Figure 1. Summary of search terms used during the literature searches according to different domains of the PICO
Patient or  
population  
or problem
Intervention Comparison Outcome
Managing patients
with chronic 
oedema in
community settings
Lymphoedema;
chronic oedema;
managing chronic  
oedema
A community-based
education model to 
support community health 
professionals and patients 
in the management and  
care of the patient’s  
chronic oedema
Exercise; compression 
hosiery; compression 
bandages; self-care
When compared to  
no education model/ 
usual care
Bandages;  
hosiery, stockings
More effective  
management of chronic 
oedema; economic and  
patient benefits
Health-related quality  
of life; cost of; burden of; 
economic evaluation,  
QALY, RCTs, service 
evaluations, systematic 
reviews, reviews
Table 2. Inclusion criteria applied in literature search
Inclusion criteria Implications
Study population Adult patients (>18 years) Studies involving only a population aged less than 18 years  
were rejected during filtering stages
Patients with chronic oedema 
in community settings
Studies on patients with other diseases were rejected during 
filtering stages
Study design RCTs, economic evaluations, 
service evaluations, systematic 
reviews, reviews
All other study types were either excluded by the searches 
or rejected during filtering stages, e.g. editorials, letters and 
comments
Outcomes Clinical Studies reporting clinical outcomes were included during filtering 
stages
Economic Studies reporting economic/cost outcomes, economic evaluations, 
cost studies, cost effectiveness studies, ICERs etc, were included
Patient reported outcomes Studies reporting health related quality of life; effective 
management of chronic oedema; patient benefits; QALY 
outcomes were included
Other English language All other language publications were excluded and rejected during 
the filtering process
Since 2000 To keep the research relevant to up to date practice, publications 
prior to 2000 were excluded by the searches
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search results were screened by checking the article’s 
title and abstract against the inclusion criteria (Table 
2). Studies that did not match the eligibility criteria 
were excluded and duplicates were removed. The full 
articles of non-excluded studies were then obtained 
and reviewed again for inclusion. Publications that 
did not fit the PICO at this stage were excluded. The 
reference lists of included papers were hand-searched 
to identify any publications that might have been 
missed during the database searches. 
RESULTS
Using Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA), a flow 
diagram was generated displaying the results of 
the search (Figure 2). Fifty-nine potentially relevant 
abstracts were found from a search of the journal 
databases. Eight papers were excluded as their 
full text was not available either electronically or 
via our inter library loan document service. A 
further 18 papers were excluded as they did not 
specifically study the management of chronic 
oedema or lymphoedema in a community setting. 
Two papers were editorials, three papers were 
duplicates and the other six papers were deemed to 
be unrelated research. Thus 21 papers were chosen 
for inclusion in the final review — eight US studies, 
four UK studies, one UK and Canadian study, four 
Australian studies, two German studies and one 
study each from Japan and Italy (Table 3). The 
papers found have been thematically categorised 
(based on health-related quality of life and cost 
burden outcomes of the study) into the following 
sections: Self-managing chronic oedema; exercise; 
compression devices; dressings/stockings; quality of 
life and cost studies/economic burden. 
SELF-MANAGING CHRONIC OEDEMA 
Ahmed et al (2011) used the self-reported data 
collected by the Iowa Women’s Health Study. 
The data consisted of information for diagnosed 
lymphoedema in 2004 and data for cancer 
diagnosis, treatment, behavioural and health 
characteristics between 1986 and 2003. The main 
aim of the study was to use this longitudinal data to 
look at the risk factors for lymphoedema and related 
arm symptoms in breast cancer survivors that the 
authors felt had not been examined. The study 
examined the data from 1,287 women from the 
cohort and they found that obesity, poorer general 
Figure 2. Summary of literature search
50 records identified
through database search:
Medine, PubMed, CINHAL
9 additional records identified 
through other sources: 
Cross referenced, Google Scholar
56 records after duplicates removed
56 records screened
8 records excluded
8 full text not available
48 full-text articles
assessed for eligibility
26 records excluded:
25 unrelated research
2 editorials
21 studies included in 
qualitative syntheses
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health and markers of more advanced cancer were 
risk factors for lymphoedema and related arm 
symptoms in breast cancer survivors.
The aim of Jeffs and Purushotham's (2016) 
study was to identify factors influencing patient 
perception of success and benefit with self-
management of breast cancer-related lymphoedema 
(BCRL). They also wanted to explore how patients 
decided whether their swollen limb had improved 
or deteriorated. The authors identified seven 
enablers and blocks to self-management: routine, 
recognising benefit of self-management and 
consequences of non-treatment, owning treatment, 
knowledge and understanding, problem-solving, 
time required for treatment and aesthetics of 
compression garments.
The study found that lymphoedema practitioners 
and oncology nurses have a valuable role in 
providing knowledge and support to patients 
transitioning to independent self-care. This was 
down to the women who participated in this study 
demonstrating varying degrees of acceptance and 
adjustment to life with lymphoedema. This in turn 
appeared to directly impact their ability to self-
manage lymphoedema. The authors concluded that 
a better understanding of factors facilitating patients 
to become experts in their condition and its 
management may improve long-term outcomes and 
reduce cost pressures on lymphoedema services.
A more recent systematic review (Douglass et al, 
2016) looked at the current evidence for effective 
lymphoedema self-care strategies that might be 
applicable to management of all types of secondary 
lymphoedema. The authors found that there was 
evidence to support the adoption of remedial 
exercises in the management of filariasis-related 
lymphoedema and for a greater emphasis on self-
treatment practices for people with cancer-related 
lymphoedema. Furthermore, empowerment of 
people with lymphoedema to care for themselves 
with access to supportive professional assistance has 
the capacity to optimise self-management practices 
and improve outcomes from limited health 
resources. There was no emphasis on the cost 
burden of lymphoedema, just the physical burden 
and quality of life of the patient.
EXERCISE
A second 2016 study by Jeff ’s et al examined BCRL 
outcomes and perceived benefit for attendees at a 
'reducing your risk of lymphoedema' class between 
2000 and 2005. All women found the class beneficial, 
reporting increased confidence to return to normal 
life and a wide range of activities/exercise. The 
authors conclude that prevalence of BCRL should be 
determined by both clinical judgement and objective 
measurement to avoid underestimation. Further, the 
benefit of group education with a lymphoedema 
expert and of exercise instruction should be further 
explored, and the potential for exercise to reduce 
BCRL prevalence should be examined.
COMPRESSION DEVICES
Mulek et al’s 2013 study aimed to examine the 
effectiveness of an advanced pneumatic compression 
device (APCD) in reducing limb volume, and to 
evaluate clinician and patient-reported outcomes. 
Patient-reported outcomes showed a significant 
increase in ability to control lymphoedema through 
APCD treatment, with an increase in function 
and a reduction in the interference of pain. The 
researchers found that APCD use was associated 
with consistent reductions in limb volume and had 
favourable patient-reported outcomes. The results 
demonstrated that reduction in limb volume and 
pain enhanced the ability to complete activities of 
daily living. Combined with functional improvement, 
patient satisfaction can be achieved
In 2016, Williams looked at the current evidence 
surrounding adjustable compression devices. 
Through reviewing the current literature, the author 
concluded that research evidence for the use of 
adjustable compression wrap devices in people with 
lymphoedema, chronic oedema, venous ulceration 
and lipoedema is very limited, with the evidence 
mostly from descriptive papers, case studies or small 
research studies. These studies were undertaken 
over a short period of time and the author did not 
concede that these reflect the long-term nature 
of the treatment. The review also highlighted the 
lack of robust economic evaluations that have been 
undertaken. However, the review conceded that the 
claims regarding cost savings by some of the studies is 
'compelling' and warrants further research.
The 2012 study by Morgan et al explored the 
challenges of treating patients with complex/severe 
forms of chronic oedema/lymphoedema with 
compression therapy. The study identified that in 
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Canada, services tend to be more rural and remote 
than in the UK, autonomous specialist practice is 
less developed and practitioners were generally 
less confident and felt more vulnerable than their 
UK colleagues. The study concluded that there is 
a need for integrated, multidisciplinary services 
in both countries, with improved education and 
training, as well as the development of cost-effective 
compression bandaging systems that can make a 
major contribution to meeting the challenges of 
contemporary lymphoedema practice.
The study by Brayton et al (2014) aimed to 
examine lymphoedema prevalence among cancer 
survivors and to characterise changes in clinical 
outcomes and costs associated with a defined 
therapeutic intervention (use of pneumatic 
compression devices [PCD]) in a representative, 
privately insured population. The impact of PCD 
use was evaluated by comparing rates of a pre-
specified set of health outcomes and costs for the 12 
months before and after, respectively, PCD receipt. 
Lymphoedema prevalence among cancer survivors 
increased from 0.95% in 2007 to 1.24% in 2013. 
PCD use was associated with decreases in rates of 
hospitalizations (45% to 32%, p<0.0001), outpatient 
hospital visits (95% to 90%, p<0.0001), cellulitis 
diagnoses (28% to 22%, p=0.003) and physical therapy 
use (50% to 41%, p<0.0001). The average baseline 
health care costs were high ($53,422) but decreased 
in the year after PCD acquisition (-$11,833, 
p<0.0001). The study concluded that lymphoedema 
is associated with high health care costs; appropriate 
treatment (in this instance, use of PCD) is associated 
with significant decreases in adverse clinical 
outcomes and costs.
COMPRESSION GARMENTS/TAPES
Mosti et al’s (2013) randomised controlled pilot 
study aimed to investigate if a kit consisting of a 
liner and outer stocking, each exerting 20 mmHg 
of pressure, would be equally effective in achieving 
and maintaining volume reduction compared 
with short-stretch bandaging (2 weeks) followed 
by a class II (23–33 mmHg) stocking (2 weeks) for 
patients with leg oedema. The authors found that 
the initial improvement in leg volume (1 week) 
was independent of the pressure applied and the 
reduction was maintained by superimposing a 
second stocking. They concluded that this liner 
and outer stocking kit offers a simple alternative 
for managing leg oedema and could allow for a 
considerable cost saving.
A meta-analysis of the effectiveness and safety of 
kinesiology taping in the management of cancer-
related lymphoedema was undertaken by Gatt 
et al (2016). Kinesiology tape is a thin, stretchy, 
elastic cotton strip with an acrylic adhesive. 
Therapeutic kinesiology tape that can benefit 
a wide variety of musculoskeletal and sports 
injuries, plus inflammatory conditions. This study 
aimed to determine the effectiveness and safety 
of kinesiotaping (KT) in the management of CRL 
compared to compression bandaging or hosiery. A 
systematic search of the literature was conducted 
until July 2015. The primary outcomes were 
reduction in body part volume or circumference 
and adverse effects of the interventions. The 
secondary outcomes were subjective experience 
of the treatment, severity of lymphoedema-related 
symptoms and patients’ quality of life. The authors 
found that where lymphoedema-related symptoms 
were reported, KT was found to be superior to 
compression. However, patients receiving bandaging 
reported a higher quality of life. KT was not found to 
be more comfortable than bandaging. The authors 
recommend KT should only be used with great 
caution where bandaging cannot be used.
QUALITY OF LIFE
Blome et al (2013) developed and then validated a 
specific version of the Patient Benefit Index (PBI) that 
measures patient-relevant benefit in lymphoedema 
and lipoedema treatment (PBI-L). The authors found 
that the PBI-L was an internally consistent, valid, and 
responsive instrument for the assessment of patient-
relevant benefits of oedema treatment.
Luchi and colleagues aimed to examine the 
associations between lymphoedema treatments and 
outcomes using a cross-sectional observational study 
of lymphoedema outpatient clinics in Japan (luchi et 
al, 2015). The study outcomes that were evaluated 
were: circumference measurements, Stemmer 
sign, cellulitis, and skin hardness. Additionally, 
subjective outcomes were evaluated: satisfaction 
with treatment, subjective symptoms, EuroQol Five-
dimensions and a quality of life measure for limb 
lymphoedema (LYMQOL). Multiple regression 
analysis was performed to examine the associations 
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between lymphoedema treatments and their 
outcomes. The study concluded that the progression 
of swelling can be evaluated using the Stemmer sign 
with regard to compression therapy. The degree of 
satisfaction can be evaluated as patients' satisfaction 
with lymphoedema regarding compression garments 
and simple lymphatic drainage, and improvements in 
quality of life can be evaluated using the LYMQOL 
with regard to complete decongestive therapy. 
The systematic literature review by Leung et 
al (2015) looked at the available evidence for the 
treatment of secondary lower limb lymphoedema in 
patients with malignancies. The authors found that 
few studies have evaluated the clinical effectiveness 
and potential side effects of treatments for lower 
limb lymphoedema. Symptoms and quality of 
life assessments were inconsistently reported and 
all included studies report lower limb volume 
reduction after treatment, which includes complex 
decongestion therapy, graded compression stockings 
and lymphovenous microsurgical shunts. The study 
concludes that adequately powered randomised 
controlled trials of these interventions are 
recommended and effort should be made to establish 
standardised outcomes, to minimise bias and to 
improve reporting quality in future trials of treatment 
for lower limb lymphoedema.
In 2016, Boyages et al (2016) examined the impact 
of BCRL on women’s work and career and claimed 
to address a significant knowledge gap regarding the 
additional impact of lymphoedema on breast cancer 
survivors. Both breast cancer and lymphoedema 
had a significant negative influence on women’s 
work and career. Respondents reported changes in 
employment resulting from stress and/or physical 
impairment, which affected attendance and work 
performance. The perceived negative impact of 
breast cancer on respondents’ work and career was 
noticeably greater in Group 2 (63 %) than Group 1 
(51 %) (p=0.03). The study identifies an additional 
detrimental effect of lymphoedema on women’s 
work and career over and above the initial impact 
of breast cancer and provides empirical evidence for 
future prospective studies and policy improvement.
The 2013, Bell et al looked at the incidence 
and prevalence of self-reported lymphoedema 
in breast cancer survivors between 2 and 4 
years following diagnosis, the factors associated 
with the development of lymphoedema and 
the impact of lymphoedema on psychological 
wellbeing. The researchers found that the 
presence of lymphoedema was associated with 
lower psychological general wellbeing. The study 
concludes that lymphoedema after breast cancer 
treatment frequently has a dynamic pattern and may 
emerge as an issue for women several years after their 
initial treatment. It is also associated with a lower 
level of general wellbeing.
Ezzo et al’s Cochrane review aimed to assess the 
efficacy and safety of manual lymphatic drainage 
(MLD) in treating BCRL (Ezzo et al, 2015). The 
authors conclude that MLD is safe and may offer 
additional benefit to compression bandaging for 
swelling reduction. Compared to individuals with 
moderate-to-severe BCRL, those with mild-to-
moderate BCRL may be the ones who benefit from 
adding MLD to an intensive course of treatment 
with compression bandaging. This finding, however, 
needs to be confirmed by randomized data. In trials 
where MLD and sleeve were compared with a non 
MLD treatment and sleeve, volumetric outcomes 
were inconsistent within the same trial. Research is 
needed to identify the most clinically meaningful 
volumetric measurement, to incorporate newer 
technologies in lymphoedema assessment, and to 
assess other clinically relevant outcomes such as 
fibrotic tissue formation. Findings were contradictory 
for function (range of motion), and inconclusive 
for quality of life. For symptoms such as pain and 
heaviness, 60% to 80% of participants reported feeling 
better regardless of which treatment they received. 
One-year follow-up suggests that once swelling had 
been reduced, participants were likely to keep their 
swelling down if they continued to use a custom-
made sleeve.
Kahn et al (2012) examined factors impacting 
long-term functional outcomes and psychological 
sequelae in survivors of breast cancer. The research 
found that factors associated with poorer current 
level of functioning and wellbeing included: 
younger participants, recent diagnoses, aggressive 
tumour types, receiving chemotherapy, shoulder 
limitation due to pain, and lymphoedema. Breast 
cancer survivors require long-term management 
of psychological sequelae impacting activity and 
participation.
One study looked at living with lymphoedema in 
older women with over 50% of breast cancer cases 
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(Clough-Gorr et al, 2010). The results showed that 
women with symptoms of persistent lymphoedema 
consistently reported worse general mental health 
and physical function. Symptoms of persistent 
lymphoedema were common in this population of 
older breast cancer survivors and had a noticeable 
effect on both physical function and general mental 
health. Further, their findings provided evidence of 
the impact of symptoms of persistent lymphoedema 
on the quality of survivorship of older women. 
Clinical and research efforts focused on risk factors 
for symptoms of persistent lymphoedema in older 
breast cancer survivors may lead to preventative 
and therapeutic measures that help maintain their 
health and wellbeing over increasing periods of 
survivorship.
In 2010, Fu et al investigated how providing 
information about BCRL affects the cognitive 
and symptomatic outcome of breast cancer 
survivors. The researchers found that breast 
cancer survivors who received information about 
BCRL had significantly reduced symptoms and 
increased knowledge about BCRL. In clinical 
practice, breast cancer survivors should be 
engaged in supportive dialogues so they can 
be educated about ways to reduce their risk of 
developing BCRL (Fu et al, 2010).
COST STUDIES/ECONOMIC BURDEN
The 2013 systematic review by Stout et al sought 
to examine the policy and economic impact 
of caring for patients with lymphoedema. As 
part of a large scale literature review aiming to 
systematically evaluate the level of evidence of 
contemporary peer-reviewed lymphoedema 
literature (2004 to 2011), publications on care 
delivery models, health policy, and economic 
impact were retrieved, summarized, and evaluated 
by a team of investigators and clinical experts 
(Stout et al, 2013). The authors concluded that 
the review substantiates lymphoedema education 
models and clinical models implemented at the 
community, health care provider and individual 
level that improve delivery of care. The review 
also exposed the lack of economic analysis related 
to lymphoedema. Medical and community-based 
disease management interventions, taking on a 
public approach, are effective delivery models 
for lymphoedema care and demonstrate great 
potential to improve cancer survivorship care. 
The researchers also concede that more research 
is needed to identify costs associated with the 
treatment of lymphoedema and to model the cost 
outlays and potential cost savings associated with 
management of chronic lymphoedema.
Basta et al (2016) aimed to estimate complicated 
lymphoedema incidence after breast cancer 
surgery and calculate associated hospital resource 
utilization.The study found a 2.3% incidence of 
complicated lymphoedema after breast cancer 
surgery. Increased health care utilization for these 
patients resulted in hospital charge accrual of more 
than $180 million in two years; or approximately 
$140,000 per patient. Complicated lymphoedema 
develops in a quantifiable number of patients. The 
health care burden of lymphoedema mandates 
further investigation into targeted, anticipatory 
management strategies for BCRL.
DISCUSSION
This rapid assessment of the literature highlights 
an encouraging amount of studies and research 
looking at the management and treatment 
of lymphoedema and chronic oedema in the 
community. These studies range from self-
management, compression devices, bandages/
stockings and quality of life. However, what 
this review does lack is evidence to highlight 
the research undertaken to estimate the cost/
economic burden of the management and 
treatment of chronic oedema in the community. 
There is a troubling paucity of studies addressing 
the costs associated with treating lymphoedema 
in both primary and secondary care, social and 
community care and patient family costs. There 
are only two studies; Stout et al (2013) and Basta 
et al (2016) that attempt to research the monetary 
cost of lymphoedema associated to breast cancer, 
and neither of these are UK based studies. 
Therefore, the results from these studies are 
helpful, but are not necessarily generalizable to the 
current Welsh setting.
SUMMARY OF EVIDENCE
Six of the studies looked at the clinical effectiveness 
of either compression bandages (Mulek et al [2013]; 
Williams [2016]; Morgan et al [2011] and Brayton et 
al [2014]) or stocking/bandages (Mosti et al [2013] 
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and Gatt et al [2016]). This is particularly important 
with regards to the authors' current research study 
as the correct and timely use of bandages and 
compression garments in the community is key to 
the intervention’s effectiveness and outcomes.
In addition, the ten studies relating to quality of 
life — Bell et al (2013), Blome et al (2013), Iuchi et al 
(2015), Leung et al (2016), Boyages et al (2016), Jeff ’s 
et al (2016), Ezzo et al (2015), Kahn et al (2012), 
Clough-Gorr et al (2010) and Fu et al (2010) — 
indicated that the health-related quality of life is an 
important factor in the study of people living with 
chronic oedema and this also reflects the burden of 
the disease on family and friends. Further, another 
encouraging factor is that seven of the studies have 
been published in the last four years (half of them 
in 2016). This also indicates that the lymphoedema 
element of chronic oedema is very much at the 
forefront of researchers’ agendas. 
However, what the review also highlights is 
the paucity of research undertaken looking at 
the benefits of diet and promotion of exercise in 
patients with chronic oedema. Exercise is seen 
as one of the most important factors of the 'Four 
cornerstones of care', i.e. skin care, movement, 
simple lymphatic drainage and garments), therefore 
further research and promotion needs to be 
undertaken in this area.    
CONCLUSION
There is sufficient evidence in the literature 
that suggests promoting self-management of 
lymphoedema, the quality of life of lymphoedema 
patients and the correct use of bandages and 
stockings is vitally important to clinical practice. 
Moreover, these have a major impact in the health 
outcomes of patients in the community. This review 
is a valuable addition to the evidence base for both 
the care and management of lymphoedema, and 
an opportunity to add valuable research into the 
economic burden of the disease.   Wuk
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Table 3. Summary of studies
Title Date Author Country Study Aim Study  
Design
Population Intervention Comparator Outcomes Theme 
Comments
Complicated breast 
cancer-related 
lymphedema: 
evaluating health 
care resource 
utilization and 
associated costs of 
management. Am J 
Surg 211(1): 133–41
2016 Basta MN, 
Fox JP, 
Kanchwala 
SK, Wu LC, 
Serletti JM, 
Kovach SJ, 
Fosnot J, 
Fischer JP.
USA Estimate the 
incidence of 
complicated 
lymphedema 
incidence 
after breast 
cancer surgery 
and calculate 
associated 
hospital resource 
utilization
Burden of care 
study using 
the Healthcare 
Cost and 
Utilisation 
Project 
(HCUP)
Women > 18 
years
No intervention No 
lymphoedema 
present
Increased health care 
utilization for these 
patients resulted in 
hospital charge accrual 
of more than $180 
million in two years; or 
approximately $140, 000 
per patient. Complicated 
lymphoedema develops 
in a quantifiable number 
of patients.
Cost Studies
Worse and worse 
off: the impact of 
lymphedema on 
work and career 
after breast cancer. 
SpringerPlus. 5: 657
2016 Boyages J, 
Kalfa S, Xu 
Y, Koelmeyer 
L, Mackie 
H, Viveros 
H, Taksa L, 
Gollan P.
Australia Impact of BCRL 
on women’s work 
and career
Longitudinal 
qualitative 
study
Women >18 
years
No intervention No 
comparator
The study identifies an 
additional detrimental 
effect of lymphedema 
on women’s work and 
career over and above 
the initial impact of 
breast cancer and 
provides empirical 
evidence for future 
prospective studies and 
policy improvement.
Quality of life
Self-Care for 
Management 
of Secondary 
Lymphedema: A 
Systematic Review. 
PLoS Negl Trop Dis 
10(6): e0004740
2016 Douglass 
J, Graves P, 
Gordon S.
Australia Current evidence 
for effective 
lymphedema 
self-care strategies 
that might be 
applicable to 
management of all 
types of secondary 
lymphedema
Systematic 
Review
All participant 
with filariasis-
related 
lymphoedema 
or cancer-
related 
lymphoedema
Self-care 
management
Usual care There is evidence to 
support the adoption 
of remedial exercises 
in the management 
of filariasis-related 
lymphoedema and 
self-treatment practices 
for people with cancer-
related lymphoedema. 
No emphasis on the cost 
burden, just the physical 
burden and quality of life 
of the patient.
Self-
Management
A meta-analysis of 
the effectiveness 
and safety of 
kinesiology taping 
in the management 
of cancer-related 
lymphoedema. 
Eur J Cancer Care 
(Engl) doi: 10.1111/
ecc.12510
2016 Gatt M, Willis 
S, Leuschner 
S.
Germany To determine 
the effectiveness 
and safety of 
kinesiotaping 
(KT) in the 
management of 
CRL compared 
to compression 
bandaging or 
hosiery
Meta-analysis Lymphoedema 
Pop.
Kinesiotaping 
(KT) in the 
management of 
CRL
Compression 
bandaging or 
hosiery
KT was not found to be 
more comfortable than 
bandaging. The authors 
recommend KT should 
only be used with great 
caution where bandaging 
cannot be used.
Stockings/
Bandages
The prevalence 
of lymphoedema 
in women who 
attended an 
information and 
exercise class to 
reduce the risk of 
breast cancer-
related upper limb 
lymphoedema 
SpringerPlus. 5: 21
2016 Jeffs E, 
Purushotham 
A.
UK Breast-cancer 
related 
lymphoedema 
(BCRL) outcomes 
and perceived 
benefit for 
attendees at a 
'reducing your risk 
of lymphoedema' 
class
Cross-sectional 
study
Women who 
attended a 
'reducing 
your risk of 
lymphoedema' 
class
Information and 
exercise class to 
reduce the risk 
of upper limb 
BCRL
Usual care All women found 
the class beneficial, 
reporting increased 
confidence to return 
to normal life and a 
wide range of activities/
exercise.
Exercise
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Exploring patient 
perception of success 
and benefit in 
self-management of 
breast cancer-related 
arm lymphoedema.  
Eur J Oncol Nurs
20(2016): 173–83
2016 Jeffs E, Ream 
E, Shewbridge 
A, Cowan-
Dickie S, 
Crawshaw 
D, Huit M, 
Wiseman T.
UK Identify factors 
influencing 
patient perception 
of success and 
benefit with self-
management of 
BCRL
Qualitative 
study using 
focus groups
Men and 
Women > 18 
years with BCRL
Self-
management of 
BCRL
Usual care The authors conclude 
that a better 
understanding of factors 
facilitating patients 
to become experts in 
their condition may 
improve longer term 
outcomes and reduce 
cost pressures on 
lymphoedema services.
Quality of life
A review of 
the evidence 
for adjustable 
compression wrap 
devices. J Wound 
Care 25(5): 242–7
2016 Williams A UK Review of the 
evidence for 
adjustable 
compression wrap 
devices
Review Lymphoedema 
Pop.
Adjustable 
compression 
wrap devices
No 
comparator
The review also 
highlights the lack 
of robust economic 
evaluations that have 
been undertaken. 
However, the review 
concedes that the 
claims regarding cost 
savings by some of the 
studies is 'compelling' 
and warrants further 
research.
Compression 
bandages
Manual lymphatic 
drainage for 
lymphedema 
following breast 
cancer treatment. 
Cochrane Database 
Syst Rev. 
21(5): CD003475
2015 Ezzo J, 
Manheimer 
E, McNeely 
ML, Howell 
DM, Weiss R, 
Johansson KI, 
Bao T, Bily L, 
Tuppo CM, 
Williams AF, 
Karadibak D
USA Cochrane review 
aimed to assess 
the efficacy and 
safety of manual 
lymphatic 
drainage (MLD) in 
treating BCRL
Cochrane 
review
Lymphoedema 
Pop.
Manual 
Lymphatic 
Drainage
Usual care One-year follow-up 
suggests that once 
swelling had been 
reduced, participants 
were likely to keep 
their swelling down if 
they continued to use a 
custom-made sleeve
Quality of life
Associations 
between the 
treatments and 
outcomes of patients 
with upper and 
lower lymphoedema 
in Japan: a 
cross-sectional 
observational study. 
Int J Nurs Stud 
52(5): 913–9
2015 Iuchi T, Dai 
M, Sanada H, 
Okuwa M, 
Nakatani T, 
Sugama J.
Japan Associations 
between 
lymphoedema 
treatments 
and outcomes 
such as limb 
circumference 
measurements, 
Stemmer sign, 
cellulitis, and skin 
hardness
Cross-sectional 
observational 
study
Lymphoedema 
Pop.
No intervention No 
comparator
The subjective outcomes 
were not associated with 
every lymphoedema 
treatment in this study, 
and the effectiveness of 
lymphoedema treatment 
can be evaluated 
using several different 
outcomes.
Quality of life
The management 
of secondary lower 
limb lymphoedema 
in cancer patients: 
a systematic review. 
Palliat Med 29(2): 
112–9
2015 Leung EY, 
Tirlapur SA, 
Meads C.
UK Available evidence 
for the treatment 
of secondary 
lower limb 
lymphoedema 
in patients with 
malignancies
Systematic 
review
Patients with 
secondary 
lower limb 
lymphoedema
Management 
of secondary 
lower limb 
lymphoedema
No 
comparator
Adequately powered 
randomised 
controlled trials of 
these interventions 
are recommended 
and effort should be 
made to establish 
standardised outcomes, 
to minimise bias and 
to improve reporting 
quality in future trials of 
treatment for lower limb 
lymphoedema.
Quality of life
Evaluation of patient-
relevant outcomes 
of lymphedema and 
lipedema treatment: 
development and 
validation of a new 
benefit tool. Eur J 
Vasc Endovasc Surg 
 47(1): 100–7
2014 Blome C, 
Augustin 
M, Heyer 
K, Knöfel J, 
Cornelsen H, 
Purwins S, 
Herberger K.
Germany Development and 
validation of a 
specific version of 
the Patient Benefit 
Index (PBI) for 
the assessment 
of benefit in 
lymphoedema 
and lipoedema 
treatment (PBI-L)
Development 
and validation 
of tool
All 
lymphoedema 
and lipoedema 
patients
No intervention No 
comparator
The authors found 
that the PBI-L was an 
internally consistent, 
valid, and responsive 
instrument for the 
assessment of patient-
relevant benefit of 
oedema treatment.
Quality of life
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Lymphedema 
prevalence and 
treatment benefits 
in cancer: impact 
of a therapeutic 
intervention on 
health outcomes 
and costs. PLoS One. 
9(12): e114597
2014 Brayton KM, 
Hirsch AT, 
O Brien PJ, 
Cheville A, 
Karaca-
Mandic P, 
Rockson SG.
USA Examine 
lymphoedema 
prevalence among 
cancer survivors 
and to characterise 
changes in clinical 
outcomes and 
costs associated 
with a defined 
therapeutic 
intervention (use 
of pneumatic 
compression 
devices [PCD])
Retrospective 
analysis of 
large private 
insurance 
claims 
database
Lymphoedema 
Pop.
Pneumatic 
Compression 
Devices [PCD]
Usual care The study concluded 
that lymphoedema is 
associated with high 
health care costs; 
treatment (in this 
instance, use of PCD) 
is associated with 
significant decreases 
in adverse clinical 
outcomes and costs.
Compression 
bandages
Lymphedema: 
experience of a 
cohort of women 
with breast cancer 
followed for 4 years 
after diagnosis in 
Victoria, Australia. 
Support Care 
Cancer. 21(7): 
2017–24
2013 Bell RJ, 
Robinson PJ, 
Barallon R, 
Fradkin P, 
Schwarz M, 
Davis SR.
Australia Incidence and 
prevalence of 
self-reported 
lymphedema in 
breast cancer 
survivors 
between 2 and 4 
years following 
diagnosis
Longitudinal 
study
Women 
diagnosed with 
invasive breast 
cancer
No intervention No 
comparator
The study concludes 
that lymphoedema after 
breast cancer treatment 
frequently has a dynamic 
pattern and may emerge 
as an issue for women 
several years after their 
initial treatment. It is 
also associated with a 
lower level of general 
wellbeing.
Quality of life
Bandages or Double 
Stockings for the 
Initial Therapy of 
Venous Oedema? 
A Randomized, 
Controlled Pilot 
Study. European 
Journal of Vascular 
and Endovascular 
Surgery 46(1): 142–8
2013 Mosti G, 
Partsch H.
Italy A kit consisting of 
a liner and outer 
stocking and the 
clinical effect of 
different pressures
Randomized 
controlled pilot 
study
Patients with 
chronic venous 
oedema
Liner and outer 
stocking
Short 
stretched 
stocking
The authors found that 
the initial improvement 
in leg volume (1 week) 
was independent of 
the pressure applied 
and the reduction 
was maintained by 
superimposing a 
second stocking. 
They concluded that 
this offers a simple 
alternative for managing 
leg oedema and could 
allow for a considerable 
cost saving.
Stockings/
Bandages
Pneumatic 
compression 
device treatment 
of lower extremity 
lymphedema elicits 
improved limb 
volume and patient-
reported outcomes. 
Eur J Vasc Endovasc 
Surg 46(4): 480–7
2013 Muluk SC, 
Hirsch AT, 
Taffe EC.
USA Examine the 
effectiveness of an 
APCD in reducing 
limb volume
Device registry 
study
196 lower 
extremety 
lymphoedema 
patients
APCD Usual care The results demonstrate 
that reduction in LV 
and pain and enhance 
the ability to complete 
activities of daily 
living. Combined with 
functional improvement, 
patient satisfaction can 
be achieved.
Compression 
bandages
A systematic 
review of care 
delivery models and 
economic analyses 
in lymphedema: 
health policy impact 
(2004–2011).
Lymphology 46(1): 
27–41
2013 Stout NL, 
Weiss R, 
Feldman JL, 
Stewart BR, 
Armer JM, 
Cormier JN, 
Shih YC.
USA Examine the 
policy and 
economic impact 
of caring for 
patients with 
lymphoedema
Systematic 
Review
Lymphoedema 
Pop.
No intervention Usual care The review exposes 
the lack of economic 
analysis related to 
lymphoedema. The 
researchers also 
concede that more 
research is needed to 
identify costs associated 
with the treatment of 
lymphoedema and to 
model the cost outlays 
and potential cost 
savings associated with 
management of chronic 
lymphoedema.
Cost Studies
Table 3. Summary of studies (continued)
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Factors associated 
with long-term 
functional outcomes 
and psychological 
sequelae in women 
after breast cancer. 
Breast 21(3): 314–20
2012 Khan F, 
Amatya B, 
Pallant JF, 
Rajapaksa I.
Australia Examine factors 
impacting long-
term functional 
outcomes and 
psychological 
sequelae in 
survivors of breast 
cancer 
Prospective 
rehabilitation 
outcome study
RMH Database 
pop.
No intervention No comparator Breast cancer survivors 
require long-term 
management of 
psychological sequelae 
impacting activity and 
participation.
Quality of life
The challenges of 
managing complex 
lymphoedema/
chronic oedema in 
the UK and Canada. 
Int Wound J 9(1): 
54–69
2012 Morgan PA, 
Murray S, 
Moffatt CJ, 
Honnor A.
UK/
Canada
The challenges of 
treating patients 
with complex/
severe forms of 
chronic oedema/
lymphoedema 
with compression
Qualitative 
study using 
focus groups
Lymphoedema 
Pop.
No intervention No 
comparator
The study concludes 
that there is a need for 
integrated, multi-
disciplinary services in 
both countries, with 
improved education 
and training, as well 
as the development 
of cost-effective 
compression bandaging 
systems that can make 
a major contribution to 
meeting the challenges 
of contemporary 
lymphoedema practice.
Self-management
Risk factors for 
lymphedema in 
breast cancer 
survivors, the Iowa 
Women’s Health 
Study December. 
Breast Cancer 
Res Treat 130(3): 
981–91
2011 Ahmed RL, 
Schmitz KH, 
Prizment AE, 
Folsom AR.
USA Look at the 
risk factors for 
lymphedema 
and related arm 
symptoms in 
breast cancer 
survivors
Population-
based 
prospective 
cohort study
Women aged 
55–69 years
No intervention No 
comparator
Obesity, poorer general 
health and markers of 
more advanced cancer 
were risk factors for 
lymphedema and 
related arm symptoms 
in breast cancer 
survivors.
Self-management
Older Breast Cancer 
Survivors: Factors 
Associated with Self-
reported Symptoms 
of Persistent 
Lymphedema Over 
7-years of Follow-up. 
Breast J
16(2): 147–55
2010 Clough-Gorr 
KM, Ganz PA, 
Silliman RA.
USA Longitudinal study Women 
> 65 years 
diagnosed with 
primary stage 
I-IIIA
Lymphoedema 
Pop.
No intervention No 
comparator
Clinical and research 
efforts focused on risk 
factors for symptoms of 
persistent lymphedema 
in older breast cancer 
survivors may lead 
to preventative and 
therapeutic measures 
that help maintain their 
health and well-being 
over increasing periods 
of survivorship.
Quality of life
The effect of roviding 
information about 
lymphedema on 
the cognitive and 
symptom outcomes 
of breast cancer 
survivors. Ann 
Surg Oncol 17(7): 
1847–53
2010 Fu MR, Chen 
CM, Haber 
J, Guth AA, 
Axelrod D.
USA Providing 
information 
about breast-
cancer related 
lymphoedema 
(BCRL) affects 
the cognitive and 
symptomatic 
outcome of breast 
cancer survivors
Cross-sectional 
study
Lymphoedema 
Pop.
Information 
about 
lymphoedema 
on the 
Cognitive and 
Symptom 
Outcomes of 
Breast Cancer
No 
information
In clinical practice, 
breast cancer survivors 
should be engaged in 
supportive dialogues so 
they can be educated 
about ways to reduce 
their risk of developing 
BCRL.
Quality of life
